Literature DB >> 16006999

Polymorphisms and haplotypes of serine hydroxymethyltransferase and risk of squamous cell carcinoma of the head and neck: a case-control analysis.

Zhengdong Zhang1, Qiuling Shi, Erich M Sturgis, Margaret R Spitz, Qingyi Wei.   

Abstract

Low dietary intake of fruits and vegetables, particularly folate deficiency, has been associated with the risk of squamous cell carcinoma of the head and neck (SCCHN). We hypothesized that polymorphisms of the cytosolic serine hydroxymethyltransferase (SHMT1) gene involved in folate-dependent, one-carbon metabolism are associated with SCCHN risk. In a hospital-based, case-control study of 721 non-Hispanic white SCCHN patients and 1,234 control subjects, frequency-matched by age and sex, three known SHMT1 polymorphisms (34761C>T, 34840C>G and 34859C>T) were genotyped. It was found that none of these three polymorphisms alone had a significant main effect on the risk of SCCHN. However, when the three polymorphisms were evaluated together by the number of the variant (risk) haplotype alleles (i.e. 34761 T, 34840G or 34859 T), the risk of SCCHN was significantly increased in a dose-response manner as the number of variant haplotype alleles increased compared to those with zero variant alleles [adjusted odd ratio (OR)=1.39, 95% confidence interval (CI)=1.14-1.70 for 1-3 variant alleles and OR=1.46, 95% CI=1.09-1.97 for 4-6 variant alleles; Ptrend=0.001]. In stratification analysis, this significant association was confined to younger men (<or=64 years), ever smokers, ever drinkers and patients whose primary tumor site was in the pharynx or larynx. In conclusion, these three SHMT1 polymorphisms may play a joint role in the etiology of SCCHN in a non-Hispanic white population.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16006999     DOI: 10.1097/01.fpc.0000170915.19522.b2

Source DB:  PubMed          Journal:  Pharmacogenet Genomics        ISSN: 1744-6872            Impact factor:   2.089


  7 in total

1.  Polymorphisms in serine hydroxymethyltransferase 1 and methylenetetrahydrofolate reductase interact to increase cardiovascular disease risk in humans.

Authors:  Susan M Wernimont; Farbod Raiszadeh; Patrick J Stover; Eric B Rimm; David J Hunter; Wenbo Tang; Patricia A Cassano
Journal:  J Nutr       Date:  2010-12-22       Impact factor: 4.798

2.  A meta-analysis of the C1420T polymorphism in cytosolic serine hydroxymethyltransferase (SHMT1) among Caucasian colorectal cancer populations.

Authors:  Noel Pabalan; Hamdi Jarjanazi; Hilmi Ozcelik
Journal:  Int J Colorectal Dis       Date:  2013-01-16       Impact factor: 2.571

3.  Genetic variation in the one-carbon transfer pathway and ovarian cancer risk.

Authors:  Linda E Kelemen; Thomas A Sellers; Joellen M Schildkraut; Julie M Cunningham; Robert A Vierkant; V Shane Pankratz; Zachary S Fredericksen; Madhura K Gadre; David N Rider; Mark Liebow; Ellen L Goode
Journal:  Cancer Res       Date:  2008-04-01       Impact factor: 12.701

4.  Polymorphisms of cytosolic serine hydroxymethyltransferase and risk of lung cancer: a case-control analysis.

Authors:  Luo Wang; Jiachun Lu; Jiaze An; Qiuling Shi; Margaret R Spitz; Qingyi Wei
Journal:  Lung Cancer       Date:  2007-04-08       Impact factor: 5.705

5.  Genetic variation in APE1 gene promoter is associated with noise-induced hearing loss in a Chinese population.

Authors:  Huanxi Shen; Jianrui Dou; Lei Han; Ying Bai; Qian Li; Zhiqiang Hong; Jian Shi; Hengdong Zhang; Feng Zhang; Cheng Du; Zhimin Tong; Baoli Zhu
Journal:  Int Arch Occup Environ Health       Date:  2015-10-27       Impact factor: 3.015

6.  Consortium analysis of gene and gene-folate interactions in purine and pyrimidine metabolism pathways with ovarian carcinoma risk.

Authors:  Linda E Kelemen; Kathryn L Terry; Marc T Goodman; Penelope M Webb; Elisa V Bandera; Valerie McGuire; Mary Anne Rossing; Qinggang Wang; Ed Dicks; Jonathan P Tyrer; Honglin Song; Jolanta Kupryjanczyk; Agnieszka Dansonka-Mieszkowska; Joanna Plisiecka-Halasa; Agnieszka Timorek; Usha Menon; Aleksandra Gentry-Maharaj; Simon A Gayther; Susan J Ramus; Steven A Narod; Harvey A Risch; John R McLaughlin; Nadeem Siddiqui; Rosalind Glasspool; James Paul; Karen Carty; Jacek Gronwald; Jan Lubiński; Anna Jakubowska; Cezary Cybulski; Lambertus A Kiemeney; Leon F A G Massuger; Anne M van Altena; Katja K H Aben; Sara H Olson; Irene Orlow; Daniel W Cramer; Douglas A Levine; Maria Bisogna; Graham G Giles; Melissa C Southey; Fiona Bruinsma; Susanne K Kjaer; Estrid Høgdall; Allan Jensen; Claus K Høgdall; Lene Lundvall; Svend-Aage Engelholm; Florian Heitz; Andreas du Bois; Philipp Harter; Ira Schwaab; Ralf Butzow; Heli Nevanlinna; Liisa M Pelttari; Arto Leminen; Pamela J Thompson; Galina Lurie; Lynne R Wilkens; Diether Lambrechts; Els Van Nieuwenhuysen; Sandrina Lambrechts; Ignace Vergote; Jonathan Beesley; Peter A Fasching; Matthias W Beckmann; Alexander Hein; Arif B Ekici; Jennifer A Doherty; Anna H Wu; Celeste L Pearce; Malcolm C Pike; Daniel Stram; Jenny Chang-Claude; Anja Rudolph; Thilo Dörk; Matthias Dürst; Peter Hillemanns; Ingo B Runnebaum; Natalia Bogdanova; Natalia Antonenkova; Kunle Odunsi; Robert P Edwards; Joseph L Kelley; Francesmary Modugno; Roberta B Ness; Beth Y Karlan; Christine Walsh; Jenny Lester; Sandra Orsulic; Brooke L Fridley; Robert A Vierkant; Julie M Cunningham; Xifeng Wu; Karen Lu; Dong Liang; Michelle A T Hildebrandt; Rachel Palmieri Weber; Edwin S Iversen; Shelley S Tworoger; Elizabeth M Poole; Helga B Salvesen; Camilla Krakstad; Line Bjorge; Ingvild L Tangen; Tanja Pejovic; Yukie Bean; Melissa Kellar; Nicolas Wentzensen; Louise A Brinton; Jolanta Lissowska; Montserrat Garcia-Closas; Ian G Campbell; Diana Eccles; Alice S Whittemore; Weiva Sieh; Joseph H Rothstein; Hoda Anton-Culver; Argyrios Ziogas; Catherine M Phelan; Kirsten B Moysich; Ellen L Goode; Joellen M Schildkraut; Andrew Berchuck; Paul D P Pharoah; Thomas A Sellers; Angela Brooks-Wilson; Linda S Cook; Nhu D Le
Journal:  Mol Nutr Food Res       Date:  2014-07-28       Impact factor: 5.914

7.  Regular Multivitamin Supplement Use, Single Nucleotide Polymorphisms in ATIC, SHMT2, and SLC46A1, and Risk of Ovarian Carcinoma.

Authors:  Linda E Kelemen; Qinggang Wang; Irina Dinu; Robert A Vierkant; Ya-Yu Tsai; Julie M Cunningham; Catherine M Phelan; Brooke L Fridley; Ernest K Amankwah; Edwin S Iversen; Andrew Berchuck; Joellen M Schildkraut; Ellen L Goode; Thomas A Sellers
Journal:  Front Genet       Date:  2012-03-19       Impact factor: 4.599

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.